Treatment Center
We will organize our current patients to Guangzhou for an extensive examination. We have established the National Center for Brittle Bone Treatment at Guangzhou's Nanfang Hospital, under the direction of Dr. Chen Jian Ting, who heads the hospital's National Osteoporosis Research Center. The center is one of the few in China that has a bone density scanner, critical to assessing OI treatment.II.

Drug Treatment Programs
Work with Aventis Pharma to start a clinical trial of their Osteoporosis drug, Actonel, which has shown to build bone density and prevent fractures in OI patients. We are also in discussions with Abiogen Pharma S.p.A, an Italian pharmaceutical company who has just won approval for OI specific treatment with a proprietary Bisphosphonate drug.